PRF Technologies (PRFX) Income towards Parent Company (2020 - 2024)

PRF Technologies (PRFX) posted quarterly Income towards Parent Company of -$7.6 million for Q2 2024, down 204.12% year-on-year from $7.3 million in Q3 2023, and down 30.63% on a QoQ basis from -$5.8 million in Q1 2024.

PRF Technologies (PRFX) Income towards Parent Company (2020 - 2024) Analysis & Trends

PRF Technologies (PRFX) has reported Income towards Parent Company for 5 consecutive years, with -$7.6 million the latest figure, recorded in Q2 2024.

  • Quarterly Income towards Parent Company fell 204.12% year-over-year to -$7.6 million in Q2 2024, while the trailing twelve-month figure through Dec 2025 was -$7.6 million (up 68.54% YoY) and the FY2025 annual result came in at -$5.0 million, up 66.16% from the prior year.
  • Income towards Parent Company slipped to -$7.6 million in Q2 2024 per PRFX's latest filing, from -$5.8 million in the prior quarter.
  • Over the last five years, Income towards Parent Company for PRFX reached as high as -$132000.0 in Q1 2020 and fell as low as -$10.7 million in Q4 2023.
  • A 5-year average of -$3.6 million and a median of -$2.3 million in 2021 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2021 — Income towards Parent Company sank 1606.06% — and 2023, when it soared 31.46%.
  • Year by year, Income towards Parent Company stood at -$4.2 million in 2020, then sank by 65.42% to -$6.9 million in 2021, then decreased by 28.75% to -$8.9 million in 2022, then retreated by 21.01% to -$10.7 million in 2023, then rose by 29.24% to -$7.6 million in 2024.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered -$7.6 million, -$5.8 million, and -$10.7 million for Q2 2024, Q1 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.69 Bn 87.82 Bn -
2 Teva Pharmaceutical Industries 35.96 Bn 32.22 Bn 1.97 Bn
3 Zoetis 32.61 Bn 30.67 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn
5 United Therapeutics 23.06 Bn 20.91 Bn 648.10 Mn
6 RedHill Biopharma 22.43 Bn 22.43 Bn -
7 Viatris 20.25 Bn 18.44 Bn 1.16 Bn
8 Neurocrine Biosciences 17.75 Bn 16.43 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 PRF Technologies 709,530.45 -3.43 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 -7.60 Mn
Mar 31, 2024 -5.82 Mn
Dec 31, 2023 -10.74 Mn
Sep 30, 2023 -1.60 Mn
Jun 30, 2023 -2.50 Mn
Mar 31, 2023 -2.66 Mn
Dec 31, 2022 -8.88 Mn
Sep 30, 2022 -2.34 Mn
Jun 30, 2022 -2.08 Mn
Mar 31, 2022 -1.91 Mn
Dec 31, 2021 -6.89 Mn
Sep 30, 2021 -2.00 Mn
Jun 30, 2021 -1.88 Mn
Mar 31, 2021 -2.25 Mn
Dec 31, 2020 -4.17 Mn
Sep 30, 2020 -700,000.00
Jun 30, 2020 -148,000.00
Mar 31, 2020 -132,000.00